191 related articles for article (PubMed ID: 30068316)
21. Dynamic Transmission Economic Evaluation of Infectious Disease Interventions in Low- and Middle-Income Countries: A Systematic Literature Review.
Drake TL; Devine A; Yeung S; Day NP; White LJ; Lubell Y
Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):124-39. PubMed ID: 26778620
[TBL] [Abstract][Full Text] [Related]
22. Bifurcation analysis informs Bayesian inference in the Hes1 feedback loop.
Higham CF
BMC Syst Biol; 2009 Jan; 3():12. PubMed ID: 19171037
[TBL] [Abstract][Full Text] [Related]
23. Development of a framework for cohort simulation in cost-effectiveness analyses using a multistep ordinary differential equation solver algorithm in R.
Frederix GW; van Hasselt JG; Severens JL; Hövels AM; Huitema AD; Raaijmakers JA; Schellens JH
Med Decis Making; 2013 Aug; 33(6):780-92. PubMed ID: 23515213
[TBL] [Abstract][Full Text] [Related]
24. Critical Analysis of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening: A Systematic Review.
Silva-Illanes N; Espinoza M
Value Health; 2018 Jul; 21(7):858-873. PubMed ID: 30005759
[TBL] [Abstract][Full Text] [Related]
25. Continuous time Markov chain approaches for analyzing transtheoretical models of health behavioral change: A case study and comparison of model estimations.
Ma J; Chan W; Tilley BC
Stat Methods Med Res; 2018 Feb; 27(2):593-607. PubMed ID: 27048681
[TBL] [Abstract][Full Text] [Related]
26. Modelling the epidemiology of infectious diseases for decision analysis: a primer.
Jit M; Brisson M
Pharmacoeconomics; 2011 May; 29(5):371-86. PubMed ID: 21504239
[TBL] [Abstract][Full Text] [Related]
27. Modelling-based evaluation of the costs, benefits and cost-effectiveness of multipathogen point-of-care tests for sexually transmitted infections in symptomatic genitourinary medicine clinic attendees.
Huntington SE; Burns RM; Harding-Esch E; Harvey MJ; Hill-Tout R; Fuller SS; Adams EJ; Sadiq ST
BMJ Open; 2018 Sep; 8(9):e020394. PubMed ID: 30201794
[TBL] [Abstract][Full Text] [Related]
28. Bayesian evaluation of budgets for endemic disease control: An example using management changes to reduce milk somatic cell count early in the first lactation of Irish dairy cows.
Archer SC; Mc Coy F; Wapenaar W; Green MJ
Prev Vet Med; 2014 Jan; 113(1):80-7. PubMed ID: 24231116
[TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
Jones-Hughes T; Snowsill T; Haasova M; Coelho H; Crathorne L; Cooper C; Mujica-Mota R; Peters J; Varley-Campbell J; Huxley N; Moore J; Allwood M; Lowe J; Hyde C; Hoyle M; Bond M; Anderson R
Health Technol Assess; 2016 Aug; 20(62):1-594. PubMed ID: 27578428
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive compartmental model and calibration algorithm for the study of clinical implications of the population-level spread of COVID-19: a study protocol.
Robinson B; Edwards JD; Kendzerska T; Pettit CL; Poirel D; Daly JM; Ammi M; Khalil M; Taillon PJ; Sandhu R; Mills S; Mulpuru S; Walker T; Percival V; Dolean V; Sarkar A
BMJ Open; 2022 Mar; 12(3):e052681. PubMed ID: 35273043
[TBL] [Abstract][Full Text] [Related]
31. Dynamic transmission models and economic evaluations of pneumococcal conjugate vaccines: a quality appraisal and limitations.
Løchen A; Anderson RM
Clin Microbiol Infect; 2020 Jan; 26(1):60-70. PubMed ID: 31055164
[TBL] [Abstract][Full Text] [Related]
32. Dynamic sensitivity analysis of biological systems.
Wu WH; Wang FS; Chang MS
BMC Bioinformatics; 2008 Dec; 9 Suppl 12(Suppl 12):S17. PubMed ID: 19091016
[TBL] [Abstract][Full Text] [Related]
33. Bayesian methods in cost-effectiveness studies: objectivity, computation and other relevant aspects.
Armero C; García-Donato G; López-Quílez A
Health Econ; 2010 Jun; 19(6):629-43. PubMed ID: 19424994
[TBL] [Abstract][Full Text] [Related]
34. The cost-effectiveness of basiliximab induction in "old-to-old" kidney transplant programs: Bayesian estimation, simulation, and uncertainty analysis.
Emparan C; Wolters H; Laukötte M; Senninger N
Transplant Proc; 2005 Jun; 37(5):2069-71. PubMed ID: 15964341
[TBL] [Abstract][Full Text] [Related]
35. Bayesian uncertainty quantification and propagation in molecular dynamics simulations: a high performance computing framework.
Angelikopoulos P; Papadimitriou C; Koumoutsakos P
J Chem Phys; 2012 Oct; 137(14):144103. PubMed ID: 23061835
[TBL] [Abstract][Full Text] [Related]
36. Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases.
Xie J; Namjoshi M; Wu EQ; Parikh K; Diener M; Yu AP; Guo A; Culver KW
J Manag Care Pharm; 2011 Oct; 17(8):621-43. PubMed ID: 21942303
[TBL] [Abstract][Full Text] [Related]
37. Framework for modelling the cost-effectiveness of systemic interventions aimed to reduce youth delinquency.
Schawo SJ; van Eeren H; Soeteman DI; van der Veldt MC; Noom MJ; Brouwer W; Busschbach JJ; Hakkaart L
J Ment Health Policy Econ; 2012 Dec; 15(4):187-96. PubMed ID: 23525837
[TBL] [Abstract][Full Text] [Related]
38. Approximate Bayesian inference for discretely observed continuous-time multi-state models.
Tancredi A
Biometrics; 2019 Sep; 75(3):966-977. PubMed ID: 30648730
[TBL] [Abstract][Full Text] [Related]
39. Bayesian calibration of a natural history model with application to a population model for colorectal cancer.
Whyte S; Walsh C; Chilcott J
Med Decis Making; 2011; 31(4):625-41. PubMed ID: 21127321
[TBL] [Abstract][Full Text] [Related]
40. Economic Evaluation of Interventions to Address Opioid Misuse: A Systematic Review of Methods Used in Simulation Modeling Studies.
Barbosa C; Dowd WN; Zarkin G
Value Health; 2020 Aug; 23(8):1096-1108. PubMed ID: 32828223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
